Literature DB >> 9025775

Cisplatin-induced inhibition of the calcium-calmodulin complex, neuronal nitric oxide synthase activation and their role in stomach distention.

R K Jarve1, S K Aggarwal.   

Abstract

Cisplatin (8 mg/kg; i.p.) treatment of Wistar rats produced no change in nitric oxide synthase (NOS) localization or its intensity for up to 5 days. However, immunohistochemically the levels of L-citrulline and the Ca(2+)-calmodulin complex were decreased after only 3 days. An in vitro experiment using an analog of calmodulin. Mero-Calmodulin-1, showed that cis-diammine-diaquacisplatinum(II), a hydrolyzed form of cisplatin, inhibited the calmodulin conformational shift from occurring through a direct interaction with the calmodulin molecule. The results indicate that distention of the stomach was due to inhibition of neuronal NOS activation by a direct interaction between cisplatin and the calcium binding sites of the calmodulin molecule.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9025775     DOI: 10.1007/s002800050581

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  6 in total

1.  Effects of neo-adjuvant chemotherapy for oesophago-gastric cancer on neuro-muscular gastric function.

Authors:  E Z H Sung; R P Arasaradnam; E M Jarvie; S James; S J Goodyear; R A Borman; D Snead; G J Sanger; C U Nwokolo
Journal:  Mol Biol Rep       Date:  2012-06-29       Impact factor: 2.316

2.  Use of top-down and bottom-up Fourier transform ion cyclotron resonance mass spectrometry for mapping calmodulin sites modified by platinum anticancer drugs.

Authors:  Huilin Li; Tzu-Yung Lin; Steve L Van Orden; Yao Zhao; Mark P Barrow; Ana M Pizarro; Yulin Qi; Peter J Sadler; Peter B O'Connor
Journal:  Anal Chem       Date:  2011-11-18       Impact factor: 6.986

3.  X-ray analysis of the effect of the 5-HT3 receptor antagonist granisetron on gastrointestinal motility in rats repeatedly treated with the antitumoral drug cisplatin.

Authors:  Gema Vera; Ana Esther López-Pérez; María Martínez-Villaluenga; Pablo Antonio Cabezos; Raquel Abalo
Journal:  Exp Brain Res       Date:  2014-05-06       Impact factor: 1.972

4.  Protein flexibility is key to cisplatin crosslinking in calmodulin.

Authors:  Huilin Li; Stephen A Wells; J Emilio Jimenez-Roldan; Rudolf A Römer; Yao Zhao; Peter J Sadler; Peter B O'Connor
Journal:  Protein Sci       Date:  2012-07-11       Impact factor: 6.725

5.  Gastric myoelectric activity during cisplatin-induced acute and delayed emesis reveals a temporal impairment of slow waves in ferrets: effects not reversed by the GLP-1 receptor antagonist, exendin (9-39).

Authors:  Zengbing Lu; Man P Ngan; Ge Lin; David T W Yew; Xiaodan Fan; Paul L R Andrews; John A Rudd
Journal:  Oncotarget       Date:  2017-10-16

6.  Neuroprotective Potential of Intranasally Delivered Sulforaphane-Loaded Iron Oxide Nanoparticles Against Cisplatin-Induced Neurotoxicity.

Authors:  Ghadha Ibrahim Fouad; Sara A M El-Sayed; Mostafa Mabrouk; Kawkab A Ahmed; Hanan H Beherei
Journal:  Neurotox Res       Date:  2022-08-15       Impact factor: 3.978

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.